CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
PrEP +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04071470
NCT04071470N/ACompleted

Increasing Family-based Support for PrEP Adherence Among Discordant Couples Through Storytelling

Vanderbilt University Medical Center·interventional·Posted Aug 28, 2019·Updated Jul 25, 2024

In Brief

A clinical study evaluating Storytelling and PrEP for HIV Infections. Completed, enrolled 128 participants across 1 site.

Detailed Summary

Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV infection but requires high levels of medication adherence, particularly among women. The purpose of this proposal is to evaluate the clinical impact and mechanisms of a family-based storytelling intervention (vs. couples counseling) to improve PrEP adherence and retention among at-risk pregnant/lactating women and their HIV-infected male partners in rural Mozambique. This potentially high impact intervention provides the opportunity to test a culturally relevant approach to PrEP engagement; if proven feasible and effective, family-based storytelling for PrEP engagement could be adopted to reduce HIV incidence among pregnant/lactating women and eliminate mother-to-child transmission (MTCT).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesMozambique

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 28, 2019
Enrollment StartJan 1, 2021
Primary CompletionJun 20, 2023
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 6.8 years ago

Interventions

Storytellingbehavioral

Couples in the storytelling intervention will receive 3 storytelling sessions- the couple can include any family or friends who they feel could support them during their treatment. Stories will include stories of couples who are supportive, those who experience difficulties, and families who do/do not support their use of PrEP

PrEPdrug

Patients at risk of HIV acquisition will be provided PrEP medications and counseling in ANC